The long-standing debate over the separation of Traditional Chinese Medicine (TCM) pharmacists and Western medicine pharmacists has once again surfaced in Taiwan’s healthcare policy discussions. The core of the conflict lies in the professional scope, certification requirements, and the perceived “market share” of the two groups.
From a patient safety perspective, the ideal situation would be a highly integrated system where pharmacists are proficient in both fields, given that many patients in Taiwan take both TCM and Western medications simultaneously. However, the reality is a fierce turf war between academic departments and professional associations.
Western medicine pharmacists argue that their rigorous scientific training makes them the most qualified to manage all drug interactions, while TCM practitioners and specialized pharmacists emphasize the unique knowledge base required for traditional herbals.
The author argues that instead of endless gatekeeping, the Ministry of Health and Welfare should focus on developing a robust real-time monitoring system for drug interactions. Such a system would be more reliable than any individual’s memory and could significantly enhance public safety.
The current deadlock is a classic example of professional arrogance hindering systemic progress. We need a pharmaceutical system that serves the needs of 21st-century patients, not one that is trapped in 20th-century guild politics. The health of the public should be the primary consideration, not the prestige or income of a particular professional group.
Note: This commentary discusses the 2018 policy debate regarding the separation of pharmacist roles.